Foresite Capital, Blueyard Capital and Arch Venture Partners have participated in a $41.5m series-A for cell coding company Bit Bio.
Foresite Capital, Blueyard Capital and Arch Venture Partners have participated in a $41.5m series-A for cell coding company Bit Bio.